NVS SEC filings (2026)
CIK 1114448 · Pharmaceutical Preparations (SIC 2834) · incorporated in V8 · fiscal year ends in December
1,422 filings on EDGAR since 2001 · 28 annual, 0 quarterly, 937 current · financial statements · earnings
What happened, last 12 months#
Every earnings release with its print, every report with its quarter, the other 8-Ks by the headline of the press release they furnish or by their items, the proxy statements, and each day an insider bought or sold — newest first, each line opening the filing on EDGAR. The index by form and year follows.
September 2026
- Sep 88-K8-K · Report of a foreign private issuer
- Sep 48-K8-K · Report of a foreign private issuer
- Sep 18-K8-K · Report of a foreign private issuer
July 2026
- Jul 218-K8-K · Report of a foreign private issuer
June 2026
- Jun 118-K8-K · Report of a foreign private issuer
April 2026
- Apr 288-K8-K · Report of a foreign private issuer
March 2026
- Mar 188-K8-K · Report of a foreign private issuer
February 2026
- Feb 4ReportAnnual report (foreign private issuer), FY2025 — net income $13.97B, EPS $7.15
- Feb 48-K8-K · Report of a foreign private issuer
- Feb 48-K8-K · Report of a foreign private issuer
January 2026
- Jan 14ProxyProxy · Proxy statements
- Jan 12ProxyProxy · Proxy statements
November 2025
- Nov 258-K8-K · Report of a foreign private issuer
- Nov 208-K8-K · Report of a foreign private issuer
- Nov 58-K8-K · Report of a foreign private issuer
October 2025
- Oct 288-K8-K · Report of a foreign private issuer
- Oct 28ProxyProxy · Proxy statements
- Oct 28ProxyProxy · Proxy statements
- Oct 278-K8-K · Report of a foreign private issuer
- Oct 27ProxyProxy · Proxy statements
- Oct 27ProxyProxy · Proxy statements
- Oct 27ProxyProxy · Proxy statements
Insider transactions#
What officers, directors and 10% holders reported on Forms 4 and 5 over the last 13 months, from the documents themselves: one insider’s trades of one kind on one day are one row, with the shares, the price range and the total as filed. Open-market buys and sells first; awards, exercises, tax withholding, gifts and employee-plan purchases are grouped below them.
No Form 4 transaction on file for NVS in the window. Transaction details are read from the documents filed since January 2026; the filings themselves are counted below.
Reports and proxy statements#
Annual reports (10-K, 20-F, 40-F), quarterly reports (10-Q), current reports (8-K, 6-K) and proxy statements, newest first. An 8-K that furnishes a press release is headed by the release’s headline, its items beneath; any other 8-K is described by its items. A form opens the press release where there is one, else the document on EDGAR, or the filing’s index where it furnishes other exhibits.
2026 · 12 filings
| Filed | What it is |
|---|---|
| Sep 8, 20266-K | Report of a foreign private issuer |
| Sep 4, 20266-K | Report of a foreign private issuer |
| Sep 1, 20266-K | Report of a foreign private issuer |
| Jul 21, 20266-K | Report of a foreign private issuer |
| Jun 11, 20266-K | Report of a foreign private issuer |
| Apr 28, 20266-K | Report of a foreign private issuer |
| Mar 18, 20266-K | Report of a foreign private issuer |
| Feb 4, 20266-K | Report of a foreign private issuer |
| Feb 4, 20266-K | Report of a foreign private issuer |
| Feb 4, 202620-F | Annual report (foreign private issuer), FY2025 — net income $13.97B, EPS $7.15 |
| Jan 14, 2026DFAN14A | Proxy statements |
| Jan 12, 2026DFAN14A | Proxy statements |
2025 · 21 filings
| Filed | What it is |
|---|---|
| Nov 25, 20256-K | Report of a foreign private issuer |
| Nov 20, 20256-K | Report of a foreign private issuer |
| Nov 5, 20256-K | Report of a foreign private issuer |
| Oct 28, 2025DFAN14A | Proxy statements |
| Oct 28, 2025DFAN14A | Proxy statements |
| Oct 28, 20256-K | Report of a foreign private issuer |
| Oct 27, 2025DFAN14A | Proxy statements |
| Oct 27, 2025DFAN14A | Proxy statements |
| Oct 27, 2025DFAN14A | Proxy statements |
| Oct 27, 20256-K | Report of a foreign private issuer |
| Sep 30, 20256-K | Report of a foreign private issuer |
| Aug 11, 20256-K | Report of a foreign private issuer |
| Jul 17, 20256-K | Report of a foreign private issuer |
| Jul 17, 20256-K | Report of a foreign private issuer |
| Jun 2, 20256-K | Report of a foreign private issuer |
| Apr 29, 20256-K | Report of a foreign private issuer |
| Apr 3, 20256-K | Report of a foreign private issuer |
| Mar 28, 20256-K | Report of a foreign private issuer |
| Jan 31, 20256-K | Report of a foreign private issuer |
| Jan 31, 20256-K | Report of a foreign private issuer |
| Jan 31, 202520-F | Annual report (foreign private issuer), FY2024 — net income $11.94B, EPS $5.87 |
2024 · 13 filings
| Filed | What it is |
|---|---|
| Dec 30, 20246-K | Report of a foreign private issuer |
| Nov 25, 20246-K | Report of a foreign private issuer |
| Oct 29, 20246-K | Report of a foreign private issuer |
| Oct 29, 20246-K | Report of a foreign private issuer |
| Sep 18, 20246-K | Report of a foreign private issuer |
| Sep 17, 20246-K | Report of a foreign private issuer |
| Aug 8, 20246-K | Report of a foreign private issuer |
| Jul 18, 20246-K | Report of a foreign private issuer |
| Apr 23, 20246-K | Report of a foreign private issuer |
| Jan 31, 20246-K | Report of a foreign private issuer |
| Jan 31, 20246-K | Report of a foreign private issuer |
| Jan 31, 202420-F | Annual report (foreign private issuer), FY2023 — net income $14.85B, EPS $7.10 |
| Jan 8, 20246-K | Report of a foreign private issuer |
2023 · 21 filings — 17 × 6-K, 2 × DFAN14A, 1 × 20-F and 1 other form
2022 · 13 filings — 11 × 6-K, 1 × 20-F, 1 × 20-F/A
2021 · 18 filings — 17 × 6-K, 1 × 20-F
2020 · 24 filings — 23 × 6-K, 1 × 20-F
2019 · 28 filings — 27 × 6-K, 1 × 20-F
2018 · 38 filings — 31 × 6-K, 6 × DFAN14A, 1 × 20-F
| Filed | What it is |
|---|---|
| Nov 6, 2018DFAN14A | Proxy statements |
| Nov 5, 2018DFAN14A | Proxy statements |
| Oct 18, 2018DFAN14A | Proxy statements |
| Oct 18, 2018DFAN14A | Proxy statements |
| Oct 18, 2018DFAN14A | Proxy statements |
| Oct 18, 2018DFAN14A | Proxy statements |
| Jan 24, 201820-F | Annual report (foreign private issuer) |
31 current reports (8-K) not listed; the year is on EDGAR.
2017 · 22 filings — 21 × 6-K, 1 × 20-F
2016 · 11 filings — 10 × 6-K, 1 × 20-F
Counted, not listed; the year is on EDGAR.
2015 · 15 filings — 14 × 6-K, 1 × 20-F
Counted, not listed; the year is on EDGAR.
2014 · 28 filings — 27 × 6-K, 1 × 20-F
Counted, not listed; the year is on EDGAR.
2013 · 19 filings — 17 × 6-K, 1 × 20-F, 1 × 6-K/A
Counted, not listed; the year is on EDGAR.
2012 · 69 filings — 68 × 6-K, 1 × 20-F
Counted, not listed; the year is on EDGAR.
2011 · 86 filings — 85 × 6-K, 1 × 20-F
Counted, not listed; the year is on EDGAR.
2010 · 85 filings — 84 × 6-K, 1 × 20-F
Counted, not listed; the year is on EDGAR.
2009 · 95 filings — 94 × 6-K, 1 × 20-F
Counted, not listed; the year is on EDGAR.
2008 · 83 filings — 82 × 6-K, 1 × 20-F
Counted, not listed; the year is on EDGAR.
2007 · 78 filings — 77 × 6-K, 1 × 20-F
Counted, not listed; the year is on EDGAR.
2006 · 68 filings — 67 × 6-K, 1 × 20-F
Counted, not listed; the year is on EDGAR.
2005 · 27 filings — 26 × 6-K, 1 × 20-F
Counted, not listed; the year is on EDGAR.
2004 · 25 filings — 24 × 6-K, 1 × 20-F
Counted, not listed; the year is on EDGAR.
2003 · 29 filings — 28 × 6-K, 1 × 20-F
Counted, not listed; the year is on EDGAR.
2002 · 38 filings — 37 × 6-K, 1 × 20-F
Counted, not listed; the year is on EDGAR.
2001 · 14 filings — 13 × 6-K, 1 × 20-F
Counted, not listed; the year is on EDGAR.
Insider, ownership and other filings#
Insider ownership (Forms 3, 4, 5 and 144), beneficial ownership (Schedules 13D and 13G), registration and prospectus (S-1, S-3, S-8, 424B and related) and the rest, counted by year, with the newest 25 of each of the latest 3 years shown. A Form 4 is one insider’s transaction report; a 13G is a passive holder above five percent.
2026 · 12 filings — 4 × S-8 POS, 3 × 144, 2 × 424B5 and 3 other forms
| Filed | What it is |
|---|---|
| Apr 30, 2026144 | Notice of proposed sale (Form 144) |
| Mar 17, 2026424B5 | Prospectus supplement |
| Mar 17, 2026FWP | Free writing prospectus |
| Mar 16, 2026424B5 | Prospectus supplement |
| Feb 12, 2026144 | Notice of proposed sale (Form 144) |
| Feb 9, 2026144 | Notice of proposed sale (Form 144) |
| Feb 4, 2026S-8 | Employee stock plan registration |
| Feb 4, 2026IRANNOTICE | Other filings |
| Jan 16, 2026S-8 POS | Other filings |
| Jan 16, 2026S-8 POS | Other filings |
| Jan 16, 2026S-8 POS | Other filings |
| Jan 16, 2026S-8 POS | Other filings |
2025 · 22 filings — 6 × SC TO-T/A, 3 × SC TO-C, 2 × 144 and 8 other forms
| Filed | What it is |
|---|---|
| Nov 4, 2025424B5 | Prospectus supplement |
| Nov 4, 2025FWP | Free writing prospectus |
| Nov 3, 2025424B5 | Prospectus supplement |
| Oct 28, 20253 | Initial insider holdings (Form 3) |
| Oct 28, 2025SC TO-T/A | Beneficial ownership |
| Oct 22, 2025SC TO-T/A | Beneficial ownership |
| Oct 20, 2025SC TO-T/A | Beneficial ownership |
| Sep 29, 2025SC TO-T | Beneficial ownership |
| Sep 9, 2025SC TO-C | Beneficial ownership |
| Jul 17, 2025SCHEDULE 13G | Other filings |
| Jun 25, 2025SC TO-T/A | Beneficial ownership |
| Jun 23, 2025SC TO-T/A | Beneficial ownership |
| Jun 17, 2025SC TO-T/A | Beneficial ownership |
| May 27, 2025SC TO-T | Beneficial ownership |
| May 23, 2025144 | Notice of proposed sale (Form 144) |
| May 1, 2025SC TO-C | Beneficial ownership |
| Apr 30, 2025SC TO-C | Beneficial ownership |
| Apr 30, 2025144 | Notice of proposed sale (Form 144) |
| Apr 8, 2025UPLOAD | Letter from the SEC staff |
| Mar 31, 2025CORRESP | Letter to the SEC |
| Mar 18, 2025UPLOAD | Letter from the SEC staff |
| Jan 31, 2025IRANNOTICE | Other filings |
2024 · 46 filings — 24 × SC TO-T/A, 6 × SC 13D/A, 3 × SC TO-C and 10 other forms
| Filed | What it is |
|---|---|
| Oct 17, 2024SC 13D/A | Active holder above 5% (Schedule 13D), amended |
| Sep 17, 2024424B5 | Prospectus supplement |
| Sep 16, 2024FWP | Free writing prospectus |
| Sep 16, 2024424B5 | Prospectus supplement |
| Sep 16, 2024F-3ASR | Registration and prospectus |
| Aug 15, 2024SC 13D/A | Active holder above 5% (Schedule 13D), amended |
| Aug 13, 2024SC TO-T/A | Beneficial ownership |
| Aug 12, 2024144 | Notice of proposed sale (Form 144) |
| Aug 7, 2024SC TO-T/A | Beneficial ownership |
| Aug 2, 2024SC TO-T/A | Beneficial ownership |
| Aug 1, 2024SC TO-T/A | Beneficial ownership |
| Jul 31, 2024SC TO-T/A | Beneficial ownership |
| Jul 30, 2024SC TO-T/A | Beneficial ownership |
| Jul 29, 2024SC TO-T/A | Beneficial ownership |
| Jul 25, 2024SC TO-T/A | Beneficial ownership |
| Jul 18, 2024SC TO-T/A | Beneficial ownership |
| Jul 11, 2024SC TO-T/A | Beneficial ownership |
| Jul 5, 2024SC TO-T | Beneficial ownership |
| Jun 21, 2024SC 13D/A | Active holder above 5% (Schedule 13D), amended |
| Jun 20, 2024SC TO-C | Beneficial ownership |
| Jun 17, 2024SC 13D/A | Active holder above 5% (Schedule 13D), amended |
| Jun 10, 2024SC 13D/A | Active holder above 5% (Schedule 13D), amended |
| Jun 4, 2024SC TO-T/A | Beneficial ownership |
| May 31, 2024SD | Specialized disclosure (conflict minerals) |
| May 28, 2024SC 13D/A | Active holder above 5% (Schedule 13D), amended |
The newest 25 of 46 shown; the full year is on EDGAR.
2023 · 9 filings — 2 × S-8 POS, 2 × UPLOAD, 1 × 144 and 4 other forms
Counted, not listed; the year is on EDGAR.
2022 · 5 filings — 1 × 3, 1 × F-6 POS, 1 × IRANNOTICE and 2 other forms
Counted, not listed; the year is on EDGAR.
2021 · 5 filings — 1 × CORRESP, 1 × IRANNOTICE, 1 × S-8 and 2 other forms
Counted, not listed; the year is on EDGAR.
2020 · 26 filings — 7 × 4, 4 × 3, 4 × S-8 POS and 10 other forms
Counted, not listed; the year is on EDGAR.
2019 · 21 filings — 11 × 4, 2 × 3, 2 × SC TO-C and 5 other forms
Counted, not listed; the year is on EDGAR.
2018 · 44 filings — 28 × 4, 5 × SC TO-T/A, 4 × 3 and 6 other forms
Counted, not listed; the year is on EDGAR.
2017 · 39 filings — 17 × 4, 3 × 3, 3 × CORRESP and 13 other forms
Counted, not listed; the year is on EDGAR.
2016 · 15 filings — 4 × 3, 4 × 4, 2 × SC 13D/A and 5 other forms
Counted, not listed; the year is on EDGAR.
2015 · 23 filings — 6 × 4, 4 × CORRESP, 3 × UPLOAD and 9 other forms
Counted, not listed; the year is on EDGAR.
2014 · 16 filings — 4 × SC 13D/A, 2 × 4, 2 × 424B5 and 8 other forms
Counted, not listed; the year is on EDGAR.
2013 · 12 filings — 6 × CORRESP, 4 × UPLOAD, 1 × IRANNOTICE and 1 other form
Counted, not listed; the year is on EDGAR.
2012 · 16 filings — 4 × CORRESP, 4 × UPLOAD, 2 × 4 and 5 other forms
Counted, not listed; the year is on EDGAR.
2011 · 52 filings — 10 × CORRESP, 8 × UPLOAD, 7 × 4 and 11 other forms
Counted, not listed; the year is on EDGAR.
2010 · 31 filings — 7 × 425, 5 × 4, 4 × SC 13D/A and 10 other forms
Counted, not listed; the year is on EDGAR.
2009 · 15 filings — 4 × 4, 2 × UPLOAD, 1 × 4/A and 8 other forms
Counted, not listed; the year is on EDGAR.
2008 · 4 filings — 3 × 4, 1 × F-3ASR
Counted, not listed; the year is on EDGAR.
2007 · 1 filing — 1 × 424B3
Counted, not listed; the year is on EDGAR.
2006 · 11 filings — 2 × 4, 2 × UPLOAD, 1 × 3 and 6 other forms
Counted, not listed; the year is on EDGAR.
2005 · 8 filings — 3 × 4, 1 × 3, 1 × 3/A and 3 other forms
Counted, not listed; the year is on EDGAR.
2004 · 4 filings — 1 × 3, 1 × 4, 1 × 424B3 and 1 other form
Counted, not listed; the year is on EDGAR.
2003 · 1 filing — 1 × SC 13G
Counted, not listed; the year is on EDGAR.
2002 · 2 filings — 1 × F-3, 1 × SC 13G/A
Counted, not listed; the year is on EDGAR.
2001 · 2 filings — 1 × F-3, 1 × SC 13G
Counted, not listed; the year is on EDGAR.
About this data#
Novartis AG (NVS) has 1,422 filings on EDGAR going back to 2001: 28 annual reports, 0 quarterly reports and 937 current reports, plus proxy statements, insider forms and ownership schedules. Its latest annual report, a 20-F, was filed on Feb 4, 2026 for the fiscal year ended Dec 31, 2025. The most recent 8-K, on Sep 8, 2026, covered a material event. Not investment advice.
Every row is a filing EDGAR lists for the registrants that have been Novartis AG, read from the SEC’s submissions index each morning; a filing accepted after that read appears the next day. Where a company changed its filing entity (a holding-company reorganisation, Google into Alphabet) the predecessor’s filings are shown for the years it filed as the company, derived from the filings themselves. Dates are the filing date; the period is the report’s own. The latest 3 years of reports are listed in full, the next years to 10 without their 8-Ks, and older years are counted; the other forms are counted too, with the newest 25 of each of the latest 3 years shown. Insider transactions are the Form 4 and Form 5 documents themselves, filed since January 2026, every number as the insider filed it: a day’s lots are summed, a blank price adds its shares and no dollars, and a purchase through an employee stock plan is a plan purchase, not insider buying. An 8-K’s headline is the first line of the press release it furnishes (Exhibit 99), read from the filing and shown word for word; where two independent readings of the exhibit do not agree, the 8-K is described by its items instead. The documents stay on sec.gov, public domain, and every link opens the SEC’s copy. ChartRow does not summarise or interpret filings.
FAQ#
- Where can I read NVS's latest 10-K?
- NVS's latest annual report, a 20-F, was filed on Feb 4, 2026 for the fiscal year ended Dec 31, 2025. It is linked above and opens on EDGAR, the SEC's own site, where every exhibit is also listed.
- When did NVS last file an 8-K?
- On Sep 8, 2026 it filed a current report. An 8-K reports a material event between quarterly reports; the one that furnishes the quarter's results is filed under Item 2.02.
- How many SEC filings has NVS made?
- 1,422 filings are on EDGAR under the registrant records that have been Novartis AG, going back to 2001; 140 of them are insider ownership forms (Forms 3, 4, 5 and 144).